Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection

被引:420
|
作者
Carter, JJ
Koutsky, LA
Hughes, JP
Lee, SK
Kuypers, J
Kiviat, N
Galloway, DA
机构
[1] Fred Hutchinson Canc Res Ctr, Program Canc Biol, Seattle, WA 98109 USA
[2] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[4] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
[5] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA
来源
JOURNAL OF INFECTIOUS DISEASES | 2000年 / 181卷 / 06期
关键词
D O I
10.1086/315498
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The relationship between human papillomavirus (HPV) DNA in the genital mucosa and serum IgG to HPV-16, -18, and -6 was studied in a cohort of 588 college women. Among women with incident HPV infections, 59.5%, 54.1%, and 68.8% seroconverted for HPV-16,-18, or -6, respectively, within 18 months of detecting the corresponding HPV DNA, Transient IBV DNA was associated with a failure to seroconvert following incident HPV infection; however, some women with persistent HPV DNA never seroconverted, Antibody responses to each type were heterogeneous, but several type-specific differences were found: seroconversion for HPV-16 occurred most frequently between 6 and 12 months of DNA detection, but seroconversion for HPV-6 coincided with DNA detection. Additionally, antibody responses to HPV-16 and -18 were significantly more likely to persist during follow-up than were antibodies to HPV-6.
引用
收藏
页码:1911 / 1919
页数:9
相关论文
共 50 条
  • [1] Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
    Villa, Luisa L.
    Ault, Kevin A.
    Giuliano, Anna R.
    Costa, Ronaldo L. R.
    Petta, Carlos A.
    Andrade, Rosires P.
    Brown, Darron R.
    Ferenczy, Alex
    Harper, Diane M.
    Koutsky, Laura A.
    Kurman, Robert J.
    Lehtinen, Matti
    Malm, Christian
    Olsson, Sven-Eric
    Ronnett, Brigitte M.
    Skjeldestad, Finn Egil
    Steinwall, Margareta
    Stoler, Mark H.
    Wheeler, Cosette M.
    Taddeo, Frank J.
    Yu, Jimmy
    Lupinacci, Lisa
    Railkar, Radha
    Marchese, Rocio
    Esser, Mark T.
    Bryan, Janine
    Jansen, Kathrin U.
    Sings, Heather L.
    Tamms, Gretchen M.
    Saah, Alfred J.
    Barr, Eliav
    VACCINE, 2006, 24 (27-28) : 5571 - 5583
  • [2] Yeast coexpression of human papillomavirus types 6 and 16 capsid proteins
    Buonamassa, DT
    Greer, CE
    Capo, S
    Yen, TSB
    Galeotti, CL
    Bensi, G
    VIROLOGY, 2002, 293 (02) : 335 - 344
  • [3] Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men
    Hagensee, ME
    Kiviat, N
    Critchlow, CW
    Hawes, SE
    Kuypers, J
    Holte, S
    Galloway, DA
    JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (03): : 625 - 631
  • [4] Sexual behavior and infection with cervical human papillomavirus types 16 and 18
    Itarat, Yuwadee
    Kietpeerakool, Chumnan
    Jampathong, Nampet
    Chumworathayi, Bandit
    Kleebkaow, Pilaiwan
    Aue-aungkul, Apiwat
    Nhokaew, Wilasinee
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2019, 11 : 489 - 494
  • [5] Antibody responses following incident anal and penile infection with human papillomavirus in teenage men who have sex with men
    Zou, Huachun
    Tabrizi, Sepehr N.
    Grulich, Andrew E.
    Hocking, Jane S.
    Garland, Suzanne M.
    Bradshaw, Catriona S.
    Cornall, Alyssa M.
    Fairley, Christopher K.
    Chen, Marcus Y.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (03) : 639 - 646
  • [6] Seroprevalence of Human Papillomavirus Types 6, 11, 16 and 18 in Chinese Women
    Ji, Jia
    Sun, Hai-Kui
    Smith, Jennifer S.
    Wang, He
    Esser, Mark T.
    Hu, Shangying
    Pretorius, Robert G.
    Chen, Wen
    Belinson, Jerome L.
    Qiao, You-Lin
    BMC INFECTIOUS DISEASES, 2012, 12
  • [7] Seroprevalence of Human Papillomavirus Types 6, 11, 16 and 18 in Chinese Women
    Jia Ji
    Hai-Kui Sun
    Jennifer S Smith
    He Wang
    Mark T Esser
    Shangying Hu
    Robert G Pretorius
    Wen Chen
    Jerome L Belinson
    You-Lin Qiao
    BMC Infectious Diseases, 12
  • [8] Measurement of the humoral immune response following an incident human papillomavirus type 16 or 18 infection in young women by a pseudovirion-based neutralizing antibody assay
    Steele, Jane
    Collins, Stuart
    Wen, Kaisheng
    Ryan, Gordon
    Constandinou-Williams, Christothea
    Woodman, Ciaran B. J.
    CLINICAL AND VACCINE IMMUNOLOGY, 2008, 15 (09) : 1387 - 1390
  • [9] Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection
    Simen-Kapeu, Aline
    Kataja, Vesa
    Yliskoski, Merja
    Syrjanen, Kari
    Dillner, Joakim
    Koskela, Pentti
    Paavonen, Jorma
    Lehtinen, Matti
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 40 (09) : 745 - 751
  • [10] Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil®)
    Siddiqui M.A.A.
    Perry C.M.
    Drugs, 2006, 66 (9) : 1263 - 1271